Search results
Cognition Therapeutics hits enrollment goal in DLB study By Investing.com
Investing.com· 17 hours agoCognition Therapeutics, Inc. (NASDAQ: CGTX), a biopharmaceutical company focused on...
Reports of ‘Ozempic Personality’ Are Bubbling Up on Social Media—What to Know
Prevention via Yahoo News· 5 days agoCan Ozempic cause personality changes? Alan says that Ozempic can “potentially” cause personality...
Does 'Brain Training' Really Improve Cognition?
Medscape· 1 day agoDoes 'Brain Training' Really Improve Cognition and Forestall Cognitive Decline? One popular approach is "brain training." While not a scientific term...
What is ‘sexsomnia’? Here’s what happens with this ‘dangerous’ sex sleep disorder
New York Post· 18 hours agoHowever, it’s very difficult to study as because most people have no recollection of their actions...
Brain function of older adults catching up with younger generations, finds study
Medical Xpress· 19 hours agoThe three-part study reviewed evidence from 60 independent research papers regarding cognition in...
Study: ‘Little Evidence’ That Cannabis Harmfully Impacts Cognition in People with HIV | High Times
High Times· 1 day agoSpecifically, a number of state medical cannabis programs list HIV/AIDS as a qualifying condition,...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoCognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders ...
Sexsomnia, a Sleep Disorder, Can Have 'Legal Consequences'
People via Yahoo News· 20 hours agoSexsomnia, as the National Library of Medicine explains, is “characterized by sexual behavior during...
Annovis’ Alzheimer’s treatment helps improve cognition in trial
WSAU Wausau· 21 hours ago(Reuters) -Annovis Bio said on Monday its Alzheimer's treatment showed significantly higher improvement in cognition in patients during a mid-stage trial. The company's drug ...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 5 days agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...